POU5F1 and lung carcinoma: Ronghua Wang et al. [38] found that Taxifolin could inhibit the stemness and EMT of lung cancer cells by inhibiting the inactivation of PI3K and OCT4, demonstrating its potential of a viable therapeutic agent for lung cancer.